Sanuwave Health Appoints New EVP for Commercial Ops

Sanuwave Health ( (SNWV) ) has shared an update.

On May 30, 2025, Sanuwave Health terminated its Chief Commercial Officer, Nanci Gilmore, without cause, and she is entitled to a severance package. Subsequently, on June 3, 2025, Dustin Libby was appointed as Executive Vice President of Commercial Operations, bringing extensive experience in scaling medical device companies, which is expected to drive growth and strengthen Sanuwave’s position in the wound care market.

Spark’s Take on SNWV Stock

According to Spark, TipRanks’ AI Analyst, SNWV is a Neutral.

The overall score is heavily influenced by financial instability and valuation concerns. Positive indicators from the earnings call provide some offsetting optimism, but technical analysis and financial performance indicate significant risks.

To see Spark’s full report on SNWV stock, click here.

More about Sanuwave Health

Sanuwave Health is a company focused on the research, development, and commercialization of patented, non-invasive medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. Their portfolio includes regenerative medicine products aimed at restoring the body’s normal healing processes, with applications in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.

Average Trading Volume: 47,785

Technical Sentiment Signal: Hold

Current Market Cap: $224.5M

Learn more about SNWV stock on TipRanks’ Stock Analysis page.